BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9203568)

  • 1. Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias.
    Kaszala K; Végh A; Papp JG; Parratt JR
    Eur J Pharmacol; 1997 Jun; 328(1):51-60. PubMed ID: 9203568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.
    Vegh A; Papp JG; Parratt J
    Br J Pharmacol; 1994 Dec; 113(4):1167-72. PubMed ID: 7534181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide.
    Kis A; Végh A; Papp JG; Parratt JR
    J Mol Cell Cardiol; 1999 Jun; 31(6):1229-41. PubMed ID: 10371697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin mediates myocardial ischaemic preconditioning against free radical injury in guinea-pig isolated heart.
    Jin ZQ; Chen X
    Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):932-5. PubMed ID: 9807666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
    Vegh A; Szekeres L; Parratt J
    Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of epinephrine-induced dysrhythmias by bradykinin: role of nitric oxide and prostaglandins.
    Rajani V; Hussain Y; Bolla BS; de Guzman FQ; Montiague RR; Igić R; Rabito SF
    Am J Cardiol; 1997 Aug; 80(3A):153A-157A. PubMed ID: 9293970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin does not mediate remote ischaemic preconditioning or ischaemia-reperfusion injury in vivo in man.
    Pedersen CM; Schmidt MR; Barnes G; Bøtker HE; Kharbanda RK; Newby DE; Cruden NL
    Heart; 2011 Nov; 97(22):1857-61. PubMed ID: 21873443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning.
    Parratt JR; Vegh A; Zeitlin IJ; Ahmad M; Oldroyd K; Kaszala K; Papp JG
    Am J Cardiol; 1997 Aug; 80(3A):124A-131A. PubMed ID: 9293965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs.
    Vegh A; Szekeres L; Parratt JR
    Br J Pharmacol; 1991 Oct; 104(2):294-5. PubMed ID: 1797297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
    Yekebas E; Treede H; Jochum M; Gippner-Steppert C; Bloechle C; Knoefel WT; Scholz J; Fink E; Izbicki JR
    Crit Care Med; 2000 Apr; 28(4):1119-27. PubMed ID: 10809293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preischemic bradykinin and ischaemic preconditioning in functional recovery of the globally ischaemic rat heart.
    Starkopf J; Bugge E; Ytrehus K
    Cardiovasc Res; 1997 Jan; 33(1):63-70. PubMed ID: 9059529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning.
    Vegh A; Szekeres L; Parratt JR
    Cardiovasc Res; 1991 Dec; 25(12):1051-3. PubMed ID: 1806235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of delayed preconditioning on myocardial regional contractility during repeated episodes of low-flow ischaemia in anaesthetized dogs: possible role of nitric oxide.
    Szigeti Z; Simon K; Parratt JR; Végh A
    Clin Sci (Lond); 2004 Feb; 106(2):201-13. PubMed ID: 14556644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase.
    Kis A; Végh A; Papp J; Parratt J
    Br J Pharmacol; 1999 Aug; 127(7):1545-50. PubMed ID: 10455308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of kinins in the endothelial protective effect of ischaemic preconditioning.
    Bouchard JF; Chouinard J; Lamontagne D
    Br J Pharmacol; 1998 Feb; 123(3):413-20. PubMed ID: 9504381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bradykinin B2-receptor antagonism on post-ischemic coronary reperfusion.
    Neuhof C; Soeffker G; Cernaianu G; Dapper F; Tillmanns H; Neuhof H
    Immunopharmacology; 1997 Jun; 36(2-3):179-83. PubMed ID: 9228544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.